Drug Approval | December 28, 2024
Shilpa Medicare's Unit IV receives Eurasia GMP approval
Both units of Shilpa Medicare (Unit IV and Unit VII), have now received GMP approval from Eurasia
Both units of Shilpa Medicare (Unit IV and Unit VII), have now received GMP approval from Eurasia
Thyrocare becomes first national diagnostic chain with 100% of its labs with NABL accreditation
The company has received the GMP Certification after successful closure of the inspection
The report also revealed that 87% of physicians agreed that FEE recommendations would help to improve the speed of recovery
The TGA approval marks a pivotal step in Rusan Pharma’s expansion into the Australian market
The GMP inspection assessed mammalian and microbial drug substance manufacturing facility sections
_256_384.jpg)
Tyvek with Renewable Attribution is designed to help reduce the carbon footprint
The recognition from Malaysia's NPRA, a member of PIC/S, opens doors to new global business opportunities
The GMP certificate will allow the manufacturing site in Hervás, Cáceres to manufacture active ingredients for the pharmaceutical industry that is based on medicinal plants
WHO estimates suggest that 150 million people worldwide are affected by Trachoma
Subscribe To Our Newsletter & Stay Updated
